Sharada Mokkapati | Cancer Biology | Best Researcher Award

Published on 20/01/202520/01/2025 by Global Academic Awards

Dr. Sharada Mokkapati | Cancer Biology | Best Researcher Award

Dr. Sharada Mokkapati, The UT MD Anderson Cancer Center, United States

Dr. Sharada Mokkapati is an Assistant Professor of Urology (Research) at UT MD Anderson Cancer Center, specializing in oncology, molecular biology, and gene therapy. With a PhD in Genetics from the University of Cologne, Germany (2007), Dr. Mokkapati has contributed significantly to bladder cancer research. She was a key team member in the first FDA-approved gene therapy for bladder cancer and has extensive experience with gene therapy vector development, RNA/DNA molecular techniques, and NextGen sequencing. Her research also includes the identification of miRNA biomarkers and the study of tumor metabolism in gene therapy responses. Dr. Mokkapati has received multiple awards, including the Dodie P. Hawn Fellowship and the Lennox K. Black International prize for excellence in medicine. She is also an adhoc reviewer for journals like BMC Cancer and has co-authored numerous influential publications on bladder cancer and cancer therapy.

Publication Profile

Scopus

Education

Dr. Sharada Mokkapati earned her PhD in Genetics from the University of Cologne, Germany, in February 2007. Her academic journey has focused on genetic research, exploring complex biological systems to understand various genetic disorders. With a robust foundation in genetic principles, she has contributed significantly to the scientific community through research, publications, and collaborations. Dr. Mokkapati’s work has emphasized advancing knowledge in molecular genetics, genetic markers, and hereditary diseases, making a lasting impact on the field. Her dedication continues to inspire the next generation of genetic researchers. 🌱📚

Professional Experience 🌟

Dr. Sharada Mokkapati has an extensive career in academia and research. Since 2020, she has served as an Assistant Professor in Urology (Research) at the UT MD Anderson Cancer Center. Previously, she was an Instructor in Urology (Research) at the same institution from 2015 to 2020. Dr. Mokkapati’s academic journey began with a postdoctoral fellowship in the Department of Genetics at UT MD Anderson Cancer Center (2008-2015). Her early career includes graduate studies in Dermatology at the University of Cologne (2002-2007), and research roles at SPIC Science Foundation and Malladi Drugs & Pharmaceuticals in India. 🧬🔬

Research Achievements 🧬🔬

Dr. Sharada Mokkapati has made significant contributions to the field of oncology and gene therapy. She was a key team member in the development of the first FDA-approved gene therapy for bladder cancer. With extensive experience in oncology, molecular biology, biochemistry, biotechnology, and biomedical research, Dr. Mokkapati has developed and validated vectors for gene therapy. She is highly proficient in RNA, DNA, protein molecular techniques, biochemical assays, and NextGen sequencing. Additionally, Dr. Mokkapati excels in using both xenograft and genetically engineered mouse models for translational biology studies and managing research-related compliance and clinical trial databases. 🧪💡

Awards and Honors 🏅🎓

Dr. Sharada Mokkapati has been recognized with several prestigious awards throughout her career. She was honored with the “Dodie P. Hawn Fellowship in Genetics” at UT MD Anderson Cancer Center. Dr. Mokkapati also received the “Travel Award-Lennox K. Black International Prize for Excellence in Medicine” for her contribution to the 12th International Symposium on Basement Membranes in Philadelphia. As a team member, she contributed to the technology transfer for amylase and tannase at SPIC Science Foundation, India. Additionally, she qualified the “National Eligibility Test for Lectureship (NET)” and received the “Dr. T. Ramachandra Rao Memorial Gold Medal” for academic excellence in her Master’s studies. 🏆🧬

Research Focus 🔬💡

Dr. Sharada Mokkapati’s research primarily focuses on oncology, molecular biology, and gene therapy in the context of bladder cancer. She has contributed extensively to the molecular profiling of bladder cancer, identifying relevant subtypes for biomarker discovery. Her work also includes the development and validation of gene therapy vectors, particularly in non-muscle invasive bladder cancer. Dr. Mokkapati is proficient in RNA/DNA/protein molecular techniques, biochemical analysis, and NextGen sequencing, using mouse models to address both basic biological and translational studies. Her efforts aim to integrate gene therapies into bladder cancer treatment paradigms. 🧬🧫🎯

Publication Top Notes

Molecular profiling of bladder cancer xenografts defines relevant molecular subtypes and provides a resource for biomarker discovery (2025) – Cited by 0 🔬📚
Integrating gene therapy into the treatment paradigm for non-muscle invasive bladder cancer (2025) – Cited by 0 🧬💡
Concomitant antihistamine administration improves survival outcomes in urothelial carcinoma treated with atezolizumab (2025) – Cited by 0 💊📈
Single-cell RNA sequencing analysis identifies acute changes in the tumor microenvironment induced by interferon α gene therapy in a murine bladder cancer model (2024) – Cited by 0 🧪🧬
Interferon gene therapy with nadofaragene firadenovec for bladder cancer: from bench to approval (2023) – Cited by 7 🏥🔬
The current status of gene therapy in bladder cancer (2023) – Cited by 8 📖🔍
Lentiviral interferon: A novel method for gene therapy in bladder cancer (2022) – Cited by 8 🧬🧪
Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non-muscle-invasive Bladder Cancer (2022) – Cited by 16 🧪🔬
TCF21 promotes luminal-like differentiation and suppresses metastasis in bladder cancer (2020) – Cited by 7 🧬💥
Generation of a novel mouse strain with conditional, cell-type specific, expression of DND1 (2019) – Cited by 2 🐁🔬

Ching-Chuan Kuo | Cancer Pharmacology | Best Researcher Award

Published on 21/12/202421/12/2024 by Global Academic Awards

Prof. Dr. Ching-Chuan Kuo | Cancer Pharmacology | Best Researcher Award

Prof. Dr. Ching-Chuan Kuo, National Health Research Institutes, Taiwan

🎓 Prof. Dr. Ching-Chuan Kuo earned her Ph.D. in food chemistry and nutraceutical functionality from National Taiwan University. She is an Investigator at the National Health Research Institutes (NHRI) and a Professor at the Biotechnology Center, National Chung Hsing University. 🔬 Her research focuses on cancer biology, experimental therapeutics, precision medicine, and translational research. Key contributions include developing four cancer drug candidates that achieved US and Taiwan FDA IND approvals. 📚 Dr. Kuo has authored 108 SCI articles with 5,153 citations, an H-index of 48, and holds two patents. Her work has transformed cancer treatment and precision therapeutics. 🧬

Publication Profile

Google Scholar

Orcid

Education Background 🎓

Prof. Dr. Ching-Chuan Kuo completed her Ph.D. in Nutritional Biochemistry and Natural Product Chemistry at the Institute of Food Science and Technology, College of Bioresources and Agriculture, National Taiwan University, Taipei, Taiwan, from September 1995 to July 2001. 🌱 Her doctoral research laid the foundation for her distinguished career in cancer biology and experimental therapeutics, blending the fields of food chemistry and biotechnology. Her strong academic background in biochemistry and natural products has driven her groundbreaking work in drug discovery and cancer treatment. 📘 This education has been crucial in her continued success and innovations in translational medicine. 🧬

Professional Experience 💼

Prof. Dr. Ching-Chuan Kuo has held various prestigious positions throughout her career. Since August 2022, she has been a jointly appointed Professor at the Biotechnology Center, National Chung Hsing University, Taiwan. 🌱 In January 2022, she became an Investigator at the Institute of Biotechnology and Pharmaceutical Research, NHRI, after serving as an Associate Investigator from 2013 to 2021. 🔬 Dr. Kuo’s journey began in 2001 as a Postdoctoral Fellow at the Division of Cancer Research, NHRI, followed by roles as a Research Associate and Assistant Investigator at the National Institute of Cancer Research. Her extensive career reflects her expertise and dedication to advancing cancer research. 🧬

Research Interests 🔬

Prof. Dr. Ching-Chuan Kuo’s research focuses on several key areas within cancer biology. Her work involves the identification and validation of novel oncotargets, the development of clinically relevant tumor models, and the discovery of new anticancer drugs. 💡 She also explores cancer pharmacology and experimental therapeutics, aiming to improve cancer treatment. Her research extends to understanding chemo- and radio-resistance mechanisms and discovering strategies to overcome them. 🧬 Additionally, Prof. Kuo is deeply invested in precision medicine and translational research, seeking to bridge the gap between laboratory findings and clinical applications to enhance cancer therapies. 🌱

Publication Top Notes

Cytotoxic triterpenes from the aerial roots of Ficus microcarpa – 259 citations, 2005 📚🍃
BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells – 259 citations, 2004 🧪💥
Effects of drying and extrusion on colour, chemical composition, antioxidant activities and mitogenic response of sweet potatoes – 196 citations, 2009 🍠🔬
4-Ketopinoresinol, a novel naturally occurring ARE activator – 142 citations, 2012 🌱💪
Salvinal, a novel microtubule inhibitor isolated from Salvia miltiorrhizae Bunge – 137 citations, 2004 🌿🔬
2,2‘-Diphenyl-1-picrylhydrazyl Radical-Scavenging Active Components from Adlay – 137 citations, 2002 🌾🧪
Surface α-enolase promotes extracellular matrix degradation and tumor metastasis – 136 citations, 2013 🧬🏙️
Antagonism of free-radical-induced damage of adlay seed – 111 citations, 2001 🌱🔬
Scaffold-hopping strategy: synthesis and biological evaluation of 5, 6-fused bicyclic heteroaromatics – 107 citations, 2011 🧬🔬
Synthesis and evaluation of 3-aroylindoles as anticancer agents – 107 citations, 2009 💊🔬
7-Aroyl-aminoindoline-1-sulfonamides as a novel class of potent antitubulin agents – 106 citations, 2006 🧪💡
Four new 6-nor-5 (6→ 7) abeo-abietane type diterpenes from the bark of Taiwania cryptomerioides – 103 citations, 2005 🌲🔬

Roger KoggeEnang | Soil Science | Best Researcher Award

Published on 30/07/202403/08/2024 by Global Academic Awards

Dr. Roger Kogge Enang | Soil Science | Best Researcher Award

Dr. Gabriel Espinosa Carrasco, University of Dschang, Cameroon

Dr. Roger Kogge Enang is a strong candidate for the Best Researcher Award due to his extensive background and contributions in soil science and environmental research. Here’s why he stands out:

Publication profile

Orcid

Extensive Research Output:

Since 2016, Dr. Enang has been actively publishing, with at least two scientific articles per year. His research spans various critical areas in soil science, including soil classification, nutrient cycling, and pollution remediation.

Educational Background:

He holds a Ph.D. and MSc in Soil Science, and a BSc in Chemistry, with a specialization in environmental chemistry and soil fertility. His academic credentials underpin his solid research foundation.

Diverse Research Interests:

His research covers vital topics such as soil mineralogy, soil organic matter, and digital soil mapping. He has contributed significantly to understanding soil properties and their implications for agriculture and environmental management.

Professional Involvement:

Dr. Enang is an active member of several professional organizations, including the Cameroon Soil Science Society and the International Network on Soil Pollution. His roles in these organizations reflect his commitment to advancing the field.

Field and Laboratory Experience:

His practical experience includes extensive soil surveys, experimental design, and advanced laboratory analyses. This hands-on expertise enhances the applicability and impact of his research findings.

Notable Publications:

Dr. Enang has published numerous peer-reviewed articles in reputable journals, demonstrating his ability to contribute valuable knowledge to the scientific community.

Given his track record of impactful research, extensive publications, and professional dedication, Dr. Roger Kogge Enang is highly suitable for the Best Researcher Award.

Maryam Azizi | food packaging | Best Researcher Award

Published on 24/06/202424/06/2024 by Global Academic Awards

Assoc Prof Dr. Maryam Azizi | food packaging | Best Researcher Award

Assoc Prof Dr. Maryam Azizi, Iran

Dr. Maryam Azizi is an Associate Professor in Iran, specializing in [insert specific field, e.g., molecular biology, nanotechnology, etc.]. With a distinguished academic career, she has significantly contributed to [insert specific area of research or notable contributions]. Dr. Azizi holds a Ph.D. from [insert university name], and her research interests include [list key research interests]. She has published numerous papers in esteemed scientific journals and has been a pivotal figure in various research projects and conferences. Dr. Azizi is also dedicated to mentoring the next generation of scientists and researchers, making substantial impacts in both academia and the broader scientific community.

Publication profile

Scopus

🎓 Education :

Tabriz University of Medical Sciences, Faculty of Health and Nutrition,Ph.D. in Food Science and Technology,2017-2021
Supervisors: Dr. Ali Ehsani and Dr. Babak Ghanbarzadeh
Thesis: Design of nanobiocomposite of polyvinyl alcohol-gelatin-zeolite 4A containing metal nanoparticles (titanium dioxide and zinc oxide) and its application to increase the shelf life of shrimp,Master’s in Food Science and Technology
2011-2014,Supervisor: Dr. Mohammad Alizadeh
Thesis: The effect of replacement of stevia and dates with sugar on physicochemical, sensory, rheological and glycemic index of ice cream,Shahid Beheshti University of Medical Sciences, Faculty of Nutrition and Food,Bachelor’s in Nutrition and Food Science,2007-2011

Experience:

Tabriz University of Medical Sciences, Faculty of Nutrition and Food Science,Research Director
2020-2021
Managed and directed research activities within the faculty.,Director of Student Research Committee
2020-2021
Led the student research initiatives, fostering an environment for academic growth and innovation.,Director of the Virtual Examinations Committee
2020-2021,Oversaw the implementation and management of virtual examinations within the faculty.,Member of the Cultural Council
2021,Contributed to the cultural and academic development of the faculty.

Key Areas of Research Expertise:

Food packaging (antimicrobial, smart, biodegradable, and nanocomposite packaging)
Investigation of food pollution and toxins with an emphasis on seafood

Awards:

Best Researcher Award,Awarded by Tabriz University of Medical Sciences for outstanding research contributions in 2021.,Top Graduate Student,Recognized as the top graduate student in the Faculty of Health and Nutrition in 2014.,Best Thesis Award,Received for the thesis titled “Design of nanobiocomposite of polyvinyl alcohol-gelatin-zeolite 4A containing metal nanoparticles (titanium dioxide and zinc oxide) and its application to increase the shelf life of shrimp” in 2021.

Publication Top Notes

State-of-the-art nanosensors and kits for the detection of antibiotic residues in milk and dairy products Abedi-Firoozjah, R., Alizadeh-Sani, M., Zare, L., … Lin, X., Jafari, S.M.

Enhanced carbohydrate-based plastic performance by incorporating cerium-based metal-organic framework for food packaging application Jafarzadeh, S., Golgoli, M., Azizi-Lalabadi, M., … Rabiee, N., Zargar, M.

Nanomaterial-based sensors for the detection of pathogens and microbial toxins in the food industry; a review on recent progress Abedi-Firoozjah, R., Ebdali, H., Soltani, M., … Zhang, F., Jafari, S.M

Starch-gelatin blend films: A promising approach for high-performance degradable food packaging Zhang, W., Azizi-Lalabadi, M., Jafarzadeh, S., Jafari, S.M.

Maillard-reaction (glycation) of biopolymeric packaging films; principles, mechanisms, food applications Zhang, W., Azizi-Lalabadi, M., Roy, S., … Castro-Muñoz, R., Jafari, S.M.

Fatemeh Moradian | Cancer Award | Best Researcher Award

Published on 24/06/202424/06/2024 by Global Academic Awards

Assoc Prof Dr. Fatemeh Moradian | Cancer Award | Best Researcher Award

Assoc Prof Dr. Fatemeh Moradian,Sari Agricultural Sciences and Natural Resources University, Iran

Dr. Fatemeh Moradian is an Associate Professor with a PhD in Biochemistry, specializing in enzymes and cancer mechanisms. She taught at Sari Agricultural Sciences and Natural Resources University for 13 years. Her research spans diverse conferences globally, focusing on biochemistry, microbiology, and biotechnology. Dr. Moradian’s extensive publications include studies on proteases, enzymes, and their applications in health and agriculture. She has conducted sabbatical research at the University of Alberta, Canada. Her work on lactoferrin and its antimicrobial and anticancer effects highlights her contributions to biomedical sciences. 🧬🔬

Publication profile

Google Scholar

🎓 Education and Academic Background

Fatemeh (Elham) Moradian holds a PhD in Biochemistry and is an Associate Professor, having earned her Bachelor’s degree in Biology from the University of Shiraz in 1996, followed by a Master’s and PhD in Biochemistry from the University of Tarbiat Modares in 2000 and 2006, respectively.

📚 Teaching Experience

She has enriched the academic community through her expertise in Biochemistry, Enzymology, Biochemical Mechanisms of Cancer, Animal Cell Culture, and Bioinformatics. Her teaching tenure spans from 2006 to 2019 at Sari Agricultural Sciences and Natural Resources University.

Research Focus

Based on the cited research publications, F. Moradian’s research focus primarily revolves around enzymology, biotechnology, and environmental applications. Moradian has contributed significantly to the isolation, purification, and characterization of enzymes such as α-amylase and protease from Bacillus species, highlighting their stability and applications in various industrial sectors. Additionally, their work extends to environmental sciences, particularly in the treatment of landfill leachate using advanced oxidation processes. Moradian has also explored the biomedical aspects of proteins like lactoferrin, emphasizing its antimicrobial and anticancer properties. Overall, Moradian’s research spans enzyme technology, bioprocessing, environmental remediation, and bioactive molecule applications. 🧪🌱